标普生物科技LOF(161127)
动态评分: 5.92分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2021-12-31 | MGNX | MacroGenics Inc | 57.23 | 0.38% |
2021-12-31 | IBRX | ImmunityBio Inc | 57.69 | 0.38% |
2021-12-31 | SGMO | Sangamo Therapeutics Inc | 56.03 | 0.37% |
2021-12-31 | PMVP | PMV Pharmaceuticals Inc | 56.67 | 0.37% |
2021-12-31 | XNCR | Xencor Inc | 53.95 | 0.36% |
2021-12-31 | NRIX | Nurix Therapeutics Inc | 54.51 | 0.36% |
2021-12-31 | IDYA | IDEAYA生物科学 | 52.36 | 0.35% |
2021-12-31 | MORF | Morphic Holding Inc | 52.98 | 0.35% |
2021-12-31 | KPTI | Karyopharm Therapeutics Inc | 50.8 | 0.34% |
2021-12-31 | BBIO | BridgeBio Pharma Inc | 50.72 | 0.33% |
2021-12-31 | ALXO | ALX Oncology Holdings Inc | 47.72 | 0.32% |
2021-12-31 | RDUS | Radius Health Inc | 47.46 | 0.31% |
2021-12-31 | KRYS | Krystal Biotech Inc | 47.18 | 0.31% |
2021-12-31 | KROS | Keros Therapeutics Inc | 44.69 | 0.3% |
2021-12-31 | GOSS | Gossamer Bio Inc | 42.59 | 0.28% |
2021-12-31 | VNDA | Vanda Pharmaceuticals Inc | 42.4 | 0.28% |
2021-12-31 | BTAI | BioXcel Therapeutics Inc | 41.62 | 0.27% |
2021-12-31 | VBIV | VBI Vaccines Inc | 40.03 | 0.26% |
2021-12-31 | REPL | Replimune Group Inc | 39.07 | 0.26% |
2021-12-31 | ITOS | iTeos Therapeutics Inc | 38.41 | 0.25% |
公告&资料
